In nasopharyngeal carcinoma, RBMS3 activates caspase-9 and PARP to promote tumor cell apoptosis in a mitochondria-dependent manner, repressing the microvessels formation via downregulating MMP2 and β-catenin [44]. Here, CASP9 is linked to nasopharyngeal carcinoma.